Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.7721
-0.0679 (-8.08%)
At close: Mar 28, 2025, 4:00 PM
0.7900
+0.0179 (2.32%)
After-hours: Mar 28, 2025, 6:19 PM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $33.70 million as of March 28, 2025. Its market cap has decreased by -48.20% in one year.
Market Cap
33.70M
Enterprise Value
19.44M
1-Year Change
-48.20%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $33.70M, a decrease of -61.99%. That is a compound annual growth rate of -22.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2025 | 36.66M | 0.66% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.68B |
| UnitedHealth Group | 475.76B |
| Johnson & Johnson | 395.14B |
| AbbVie | 357.40B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 228.57B |
| Merck & Co. | 225.58B |
| AstraZeneca | 225.00B |